Clinical Significance of Leukocyte Cell Population Data in Patients with Myeloproliferative Neoplasms (MPNs)

Launched by ASSIUT UNIVERSITY · Dec 22, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on studying a group of blood disorders known as myeloproliferative neoplasms (MPNs), which affect how the body produces blood cells. These disorders can be classified into two main types: those with a specific genetic change called the Philadelphia chromosome and those without it. The goal of the study is to look at specific types of white blood cells in patients with MPNs and understand how these cell populations relate to the patients’ health and symptoms.

To participate in this trial, individuals need to be diagnosed with MPNs according to the latest guidelines from the World Health Organization. Unfortunately, those with other types of blood disorders will not be included. Since the trial is not yet recruiting, potential participants will have to wait for the study to start, but those who join can expect to undergo tests that will help researchers learn more about their blood cell counts and how these may impact their overall condition. This information could be important for better understanding and managing MPNs in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with MPNs according to the recent WHO classification.
• Exclusion Criteria:
• • Patients with other types of myeloid neoplasms and/or not fulfil the WHO criteria for MPNs diagnosis.